Turn Therapeutics Inc. (TTRX) shareholders
Close on Nov 17, 2026Market cap $254.69MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Bradley Burnam | 15,716,260 | 52.76% | 13G (passive) | Dec 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of TTRX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| SteelPeak Wealth, LLC | 249,456 | 0.84% | $1.82M | New | 0.05% |
| Ieq Capital, LLC | 227,396 | 0.76% | $1.66M | New | 0.01% |
| DDFG, Inc | 107,829 | 0.36% | $787.15K | +37,295 | 0.16% |
| Vanguard Capital Management LLC | 74,301 | 0.25% | $542.40K | +24,851 | 0.00% |
| Wellington Shields & Co., LLC | 65,732 | 0.22% | $479.84K | – | 0.11% |
| Millennium Management LLC | 60,551 | 0.20% | $442.02K | −9,206 | 0.00% |
| BlackRock, Inc. | 38,591 | 0.13% | $281.72K | New | 0.00% |
| Aaron Wealth Advisors LLC | 32,564 | 0.11% | $237.72K | New | 0.01% |
| Tamar Securities, LLC | 30,000 | 0.10% | $219.00K | – | 0.02% |
| Royal Bank of Canada | 28,250 | 0.09% | $206.00K | New | 0.00% |
| Bridgewater Advisors Inc. | 27,326 | 0.09% | $241.56K | New | 0.01% |
| Citadel Advisors LLC | 25,874 | 0.09% | $188.88K | New | 0.00% |
| Brown Brothers Harriman & Co | 23,688 | 0.08% | $172.92K | – | 0.00% |
| HighTower Advisors, LLC | 19,684 | 0.07% | $143.69K | – | 0.00% |
| RVW Wealth, LLC | 18,000 | 0.06% | $131.40K | – | 0.01% |
| Geode Capital Management, LLC | 17,142 | 0.06% | $125.14K | – | 0.00% |
| Jefferies Financial Group Inc. | 16,300 | 0.05% | $118.99K | New | 0.00% |
| Miracle Mile Advisors, LLC | 16,000 | 0.05% | $116.80K | – | 0.00% |
| McCarthy Asset Management, Inc. | 15,018 | 0.05% | $109.63K | New | 0.05% |
| Bank Of America Corp /De/ | 14,124 | 0.05% | $103.11K | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 29 | 1M | 3.9% | 11 / 4 | 2 / 2 | 1M | 0M |
| Q1 2026 | 20 | 0M | 1.6% | 3 / 3 | 2 / 4 | 0M | 0M |
| Q4 2025 | 22 | 0M | 1.6% | 22 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
6 funds held TTRX in Q2 2026, 77% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of TTRX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 62,749 | 0.21% | $458.07K | 0.00% | Jun 30, 2026 |
| iShares Micro-Cap ETF | 36,232 | 0.12% | $264.49K | 0.02% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 17,142 | 0.06% | $89.14K | 0.00% | May 31, 2026 |
| Vanguard Balanced Index Fund | 9,897 | 0.03% | $72.25K | 0.00% | Jun 30, 2026 |
| 1290 VT Micro Cap Portfolio | 2,359 | 0.01% | $17.22K | 0.01% | Jun 30, 2026 |
| Victory Extended Market Index Fund | 1,244 | 0.00% | $10.40K | 0.00% | Jul 31, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 129 | 0.00% | $942 | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Bradley Evan Burnam | Chief Executive Officer, Director, 10% owner | 15,416,260 | 51.75% | Jun 1, 2026 |
| Neilesh Shailesh Ghodadra | Chief Medical Officer, Director | 10,000 | 0.03% | Oct 10, 2025 |
| Zuraiz Chaudhary | See Remarks | 12,500 | 0.04% | Apr 3, 2026 |
| Kent Edward Kester | Director | 10,000 | 0.03% | Jun 8, 2026 |
| Andrew Gengos | Director | 10,000 | 0.03% | Jun 8, 2026 |
| Martin William Dewhurst | Director | 21,882 | 0.07% | Jun 8, 2026 |
| Arthur F. Golden | Director | 360,602 | 1.21% | Jun 8, 2026 |
| BEB Holdings, LLC | 10% owner | 15,716,260 | 52.76% | Jun 1, 2026 |
| Abraham Chesed | – | 1,447,268 | 4.86% | Oct 29, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Bradley Evan Burnam Chief Executive Officer, Director, 10% owner | May 28, 2026 | Gift | −300,000 | – | – | 15,116,260 |
| Bradley Evan Burnam Chief Executive Officer, Director, 10% owner | May 28, 2026 | Gift | +300,000 | – | – | 300,000 |
| Bradley Evan Burnam Chief Executive Officer, Director, 10% owner | May 28, 2026 | Gift | −300,000 | – | – | 15,416,260 |
| Bradley Evan Burnam Chief Executive Officer, Director, 10% owner | May 28, 2026 | Gift | +300,000 | – | – | 300,000 |
| Arthur F. Golden Director | Apr 2, 2026 | Gift | +300,000 | – | – | 360,602 |
| BEB Holdings, LLC 10% owner | Apr 2, 2026 | Gift | −300,000 | – | – | 15,716,260 |
| Martin William Dewhurst Director | Jan 7, 2026 | Award | +21,882 | – | – | 21,882 |
| Zuraiz Chaudhary See Remarks | Dec 12, 2025 | Buy | +2,500 | $3.50 | $8.75K | 12,500 |
| Arthur F. Golden Director | Nov 24, 2025 | Buy | +9,868 | $3.44 | $33.95K | 60,602 |
| Arthur F. Golden Director | Nov 21, 2025 | Buy | +20,532 | $2.87 | $58.93K | 50,734 |
| Zuraiz Chaudhary See Remarks | Nov 21, 2025 | Buy | +1,000 | $3.29 | $3.29K | 10,000 |
| Zuraiz Chaudhary See Remarks | Nov 20, 2025 | Buy | +1,450 | $2.61 | $3.78K | 9,000 |
| Zuraiz Chaudhary See Remarks | Nov 17, 2025 | Buy | +2,500 | $3.62 | $9.05K | 7,550 |
| Abraham Chesed – | Oct 23, 2025 | Buy | +14,286 | $4.60 | $65.72K | 1,447,268 |
| Arthur F. Golden Director | Oct 23, 2025 | Buy | +20,202 | $4.95 | $100.00K | 30,202 |
| Zuraiz Chaudhary See Remarks | Oct 23, 2025 | Buy | +5,050 | $4.95 | $25.00K | 5,050 |
| Neilesh Shailesh Ghodadra Chief Medical Officer, Director | Oct 8, 2025 | Award | +10,000 | – | – | 10,000 |
| Andrew Gengos Director | Oct 8, 2025 | Award | +10,000 | – | – | 10,000 |
| Arthur F. Golden Director | Oct 8, 2025 | Award | +10,000 | – | – | 10,000 |
| Kent Edward Kester Director | Oct 8, 2025 | Award | +10,000 | – | – | 10,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Turn Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 19,577 shares on Sep 21, 2026 over the last 90 days.
See a number that looks wrong?